M
M. Talpaz
Publications - 1
Citations - 928
M. Talpaz is an academic researcher. The author has contributed to research in topics: Adverse effect & Vascular endothelial growth factor. The author has an hindex of 1, co-authored 1 publications receiving 899 citations.
Papers
More filters
Journal ArticleDOI
Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer
Michael S. Gordon,Kim Margolin,M. Talpaz,George W. Sledge,E. Holmgren,R. Benjamin,Susan Stalter,S. Shak,Daniel C. Adelman +8 more
TL;DR: Multiple doses of rhuMAb VEGF were well tolerated, and pharmacokinetic studies indicate that doses of > or = 0.3 mg/kg have a half-life similar to that of other humanized antibodies.